Pasithea Therapeutics Corp. (KTTA) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15.06K | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | -100% | - | - | - | - | - | - |
| Cost of Goods Sold | 157.54K | 157.96K | 0 | 0 | 0 | 162.26K | 0 | 0 | 0 | 162.22K | 0 | 0 | 0 | 4.14K | 0 | 957 | 12.94K | 17.27K | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 114.69% | - | - |
| Gross Profit | -157.54K | -157.96K | 0 | 0 | 0 | -162.26K | 0 | 0 | 0 | -162.22K | 0 | 0 | 0 | -4.14K | 0 | -957 | 721 | -2.21K | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -14.69% | - | - |
| Gross Profit Growth % | - | 2.65% | - | - | - | -0.02% | - | - | - | -3820.28% | - | 100% | -100% | -86.99% | - | - | - | - | - | - |
| Operating Expenses | 4.72M | 10.1M | 3.11M | 3.81M | 3.68M | 3.1M | 3M | 3.95M | 4.04M | 4.99M | 3.79M | 3.83M | 3.21M | 4.04M | 3.86M | 2.61M | 2.07M | 1.95M | 1.27M | 727.95K |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 12973.34% | - | - |
| Selling, General & Admin | 1.93B | 7.51M | 1.75M | 1.66M | 1.95M | 1.59M | 1.42M | 1.59M | 2.29M | 1.64M | 2.16M | 1.8M | 2.12M | 2.65M | 2.58M | 2.61M | 2.08M | 0 | 0 | 0 |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 2.94B | 2.74M | 1.36M | 2.15M | 1.73M | 1.51M | 1.58M | 2.36M | 1.75M | 3.35M | 1.62M | 2.03M | 1.1M | 1.39M | 1.28M | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | -1000K | -157.96K | 0 | 0 | 655 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -12.94K | 1000K | 1000K | 727.95K |
| Operating Income | -4.88M | -10.26M | -3.11M | -3.81M | -3.68M | -3.26M | -3M | -3.95M | -4.04M | -5.15M | -3.79M | -3.83M | -3.21M | -4.04M | -3.86M | -2.61M | -2.08M | -1.96M | -1.27M | -727.95K |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -12988.03% | - | - |
| Operating Income Growth % | -32.51% | -214.65% | -3.51% | 3.4% | 8.92% | 36.69% | 20.71% | -3.04% | -25.78% | -27.36% | 1.72% | -46.61% | -54.53% | -106.66% | -202.74% | -258.76% | -278.25% | - | - | - |
| EBITDA | -4.72M | -10.1M | -2.93M | -3.65M | -3.52M | -3.1M | -2.84M | -3.78M | -3.88M | -4.99M | -3.63M | -3.67M | -3.05M | -4.04M | -3.84M | -2.61M | -1.29M | -1.96M | 0 | 0 |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -12985.74% | - | - |
| EBITDA Growth % | -34.12% | -226.05% | -3.03% | 3.53% | 9.28% | 37.89% | 21.64% | -3.17% | -27.13% | -23.47% | 5.52% | -40.44% | -135.84% | -106.49% | - | - | - | - | - | - |
| D&A (Non-Cash Add-back) | 157.54K | 157.54K | 181.59K | 161.75K | 161.71K | 162.26K | 162.26K | 162.26K | 162.26K | 162.22K | 162.26K | 162.26K | 161.72K | 4.14K | 16.67K | 957 | 0 | 345 | 1.27M | 727.95K |
| EBIT | -4.88M | -10.26M | -3.11M | -3.81M | -3.68M | -3.18M | -3M | -3.95M | -4.04M | -5.03M | -3.79M | -3.83M | -3.21M | -4.05M | -4.19M | -2.19M | -1.29M | -1.96M | -1.27M | -727.95K |
| Net Interest Income | 450.34K | 182.13K | 43.4K | 54.42K | 47.24K | 80.48K | 75.08K | 114.41K | 153.22K | 172.82K | 131.74K | 117.19K | -6.39K | 0 | 0 | 0 | 0 | 0 | -508 | 0 |
| Interest Income | 450.34K | 182.13K | 43.4K | 54.42K | 47.24K | 80.48K | 75.08K | 114.41K | 153.22K | 172.82K | 131.74K | 117.19K | 0 | 102 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.39K | 102 | 0 | 0 | 0 | 0 | 508 | 0 |
| Other Income/Expense | 2.01M | 145.29K | 72.64K | 94.74K | 116.94K | 81.89K | 4.77K | 78.78K | 179.93K | 117.52K | 176.74K | 230.62K | -53.26K | -10.59K | -335.32K | 421.7K | 785.3K | 2.59M | -252.51K | 0 |
| Pretax Income | -2.87M | -10.11M | -3.04M | -3.72M | -3.56M | -3.18M | -3M | -3.87M | -3.86M | -5.03M | -3.61M | -3.6M | -3.27M | -4.05M | -4.19M | -2.19M | -1.29M | 630.14K | -1.53M | -727.95K |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 4183.66% | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -2.87M | -10.11M | -3.04M | -3.72M | -3.56M | -3.18M | -3M | -3.87M | -3.86M | -5.05M | -3.61M | -3.76M | -3.54M | -5.12M | -4.59M | -2.66M | 41.35K | 630.14K | -1.53M | -727.95K |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 4183.66% | - | - |
| Net Income Growth % | 19.47% | -218.19% | -1.25% | 3.88% | 7.71% | 37.05% | 16.96% | -2.74% | -9.13% | 1.36% | 21.23% | -41.56% | -8654.62% | -912.15% | -200.51% | -265.19% | 107.52% | - | - | - |
| Net Income (Continuing) | -2.87M | -10.11M | -3.04M | -3.72M | -3.56M | -3.18M | -3M | -3.87M | -3.86M | -5.03M | -3.61M | -3.6M | -3.27M | -4.05M | -4.19M | -2.19M | -1.29M | 630.14K | -1.53M | -727.95K |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -16.89K | 0 | -165.15K | -271.87K | -1000K | -395.09K | -468.54K | -280.66K | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.41 | -0.89 | -0.41 | -0.66 | -3.25 | -2.90 | -2.87 | -3.71 | -3.70 | -4.85 | -2.87 | -2.88 | -211.05 | -3.00 | -3.45 | -2.27 | -1.37 | 0.55 | -2.31 | -1.06 |
| EPS Growth % | 87.38% | 69.31% | 85.71% | 82.21% | 12.16% | 40.21% | 0% | -28.82% | 98.25% | -61.67% | 16.81% | -27% | -15323.12% | -647.65% | -49.3% | -114.63% | -71.52% | - | - | - |
| EPS (Basic) | -0.41 | -0.89 | -0.41 | -0.66 | -3.25 | -2.90 | -2.87 | -3.71 | -3.70 | -4.85 | -2.87 | -2.88 | -211.05 | -3.00 | -3.45 | -2.27 | -1.37 | 0.55 | -2.31 | -1.06 |
| Diluted Shares Outstanding | 7.03M | 7.03M | 7.44M | 5.64M | 1.1M | 1.1M | 1.04M | 1.04M | 1.04M | 1.04M | 1.26M | 1.31M | 1.3M | 1.3M | 1.33M | 1.17M | 1.15M | 1.15M | 660.42K | 688.92K |
| Basic Shares Outstanding | 7.03M | 7.03M | 7.44M | 5.64M | 1.1M | 1.1M | 1.04M | 1.04M | 1.04M | 1.04M | 1.26M | 1.31M | 1.3M | 1.3M | 1.33M | 1.17M | 1.15M | 1.15M | 660.42K | 688.92K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |